NEOS Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52M Buy
404,459
+40,020
+11% +$4.68M 0.19% 91
2026
Q1
$43.8M Sell
364,439
-45,111
-11% -$5.21M 0.22% 82
2025
Q4
$43.1M Buy
409,550
+61,866
+18% +$5.81M 0.25% 74
2025
Q3
$29.2M Buy
347,684
+99,074
+40% +$8.16M 0.22% 83
2025
Q2
$19.7M Buy
248,610
+44,085
+22% +$3.5M 0.24% 78
2025
Q1
$18.4M Buy
204,525
+59,188
+41% +$5.53M 0.35% 53
2024
Q4
$14.5M Buy
145,337
+10,899
+8% +$1.12M 0.34% 51
2024
Q3
$15.3M Buy
134,438
+23,402
+21% +$2.78M 0.46% 44
2024
Q2
$13.7M Buy
111,036
+38,792
+54% +$5M 0.57% 30
2024
Q1
$9.53M Buy
72,244
+23,627
+49% +$2.91M 0.59% 34
2023
Q4
$5.3M Buy
48,617
+14,657
+43% +$1.52M 0.5% 40
2023
Q3
$3.5M Buy
+33,960
New +$3.66M 0.45% 46

Other funds holding MRK

NEOS Investment Management's MRK Position: Q2 2026 in Review

NEOS Investment Management increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $4.68M and bringing the position to 404,459 shares worth $52M. The position accounts for 0.19% of the portfolio, ranked #91.

NEOS Investment Management first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • NEOS Investment Management held 404,459 shares of Merck worth $52M as of Q2 2026.
  • NEOS Investment Management bought 40,020 Merck shares in Q2 2026, an estimated $4.68M.
  • Merck made up 0.19% of NEOS Investment Management's portfolio in Q2 2026, its #91 holding.
  • NEOS Investment Management first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.